Home Tags Medical Research
Tag: Medical Research News
AUSTIN, Texas, Oct. 12, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce the successful product registration of STEMREGEN® in Spain. This announcement coincides with Christian Drapeau's, CEO and Chief Scientist of Kalyagen, trip to Madrid, Spain last week to speak at the IV Jornadas Internacionales Otto H. Warburg symposium at the NH Madrid Príncipe de Vergara.
ATLANTA, Ga., Oct. 6, 2021 (SEND2PRESS NEWSWIRE) -- Purple Pansies, a pancreatic cancer nonprofit organization, recently held its 12th annual Pillars of Hope Gala, presented by Kroger, raising more than $1 million in one evening. The gala was officially renamed Pillars of Hope by the nonprofit to show support for survivors and the hope to cure pancreatic cancer.
COQUITIAM, B.C., Oct. 5, 2021 (SEND2PRESS NEWSWIRE) -- Aging is a reality that we all deal with, with age-related diseases creating a massive burden on our healthcare system. Now, Drink HRW reports that a new randomized, placebo controlled clinical trial that followed elderly participants for 6 months, published online October 1st in Experimental Gerontology, explains that high doses of hydrogen water (HRW), delivered via hydrogen tablets, could be an effective strategy at improving multiple age-related measurements and outcomes in an elderly population.
TEANECK, N.J., Sept. 20, 2021 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the 5th Annual Global C. diff. Awareness Walks will take place on-demand, on a livestream, and in-person at Sims Park, New Port Richey, FL, and Brown Street Park Complex, Spring city, PA, and Milton A. Votee, Teaneck, NJ. This year's annual events will take place on Saturday, September 25, 2021, from 9 a.m. - 12 p.m. EDT.
Pure Transplant Solutions, LLC Announces Research Collaboration with the Department of Surgery at the University of Cambridge
AUSTIN, Texas and CAMBRIDGE, U.K., July 21, 2021 (SEND2PRESS NEWSWIRE) -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The University of Cambridge Abdominal Transplant Centre at Addenbrooke's Hospital.
HAMPTON, N.J., June 3, 2021 (SEND2PRESS NEWSWIRE) -- Three researchers have published a groundbreaking paper on the importance of oral bacteria in the fight against infectious diseases like influenza, HIV, and COVID-19, Gingivax LLC announced today.
DEERIELD BEACH, Fla., May 21, 2021 (SEND2PRESS NEWSWIRE) -- Overcoming the numerous obstacles imposed by the pandemic, The Pap Corps Champions for Cancer Research displayed their indomitable spirit during their May Presidents Zoom meeting when they announced a $2 million donation to Sylvester Comprehensive Cancer Center.
Pure MHC, LLC Announces Launch of Contract Research Service Division and Initial Collaboration Project with argenx
AUSTIN, Texas, March 31, 2021 (SEND2PRESS NEWSWIRE) -- Pure MHC, LLC, a target discovery and development company, today announced the launch of its contract research services arm, Pure MHC Solutions, and an initial collaboration project with global immunology company, argenx.
TAMPA, Fla., March 16, 2021 (SEND2PRESS NEWSWIRE) -- C Diff Foundation, the leading Global Patient and Healthcare Organization Educating and Advocating for C. difficile (Clostridioides difficile, C. diff., CDAD, CDI) today announced that the organization has developed a free mobile application designed specifically for patients and families who have been impacted by a Clostridioides difficile infection.
Pure Transplant Solutions Announces Collaboration with King’s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with...
AUSTIN, Texas and LONDON, England, Feb. 24, 2021 (SEND2PRESS NEWSWIRE) -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King's College London.
Flightpath Biosciences Launches via Illumina Accelerator: Will Conduct Largest Clinical Biomarker Study in Lyme Disease
BERKELEY, Calif. /California Newswire/ -- Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator's second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD).
Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN® and Stem Cells for Advanced Heart Failure Patients
AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.
Pure Protein, LLC and Pure Transplant Solutions, LLC Promote Blake Harlan to President and Dr. Rico Buchli to Vice President of...
AUSTIN, Texas and OKLAHOMA CITY, Okla., Feb. 4, 2021 (SEND2PRESS NEWSWIRE) -- Pure Protein, LLC (Pure Protein) and subsidiary company Pure Transplant Solutions, LLC (PTS), announced today that Blake Harlan has been promoted to President and Rico Buchli, PhD to Vice President of Products and Services.
AUSTIN, Texas and BASEL, Switzerland, Jan. 27, 2021 (SEND2PRESS NEWSWIRE) -- Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The Transplantation Immunology & Nephrology Department of the University Hospital of Basel.
Drink HRW Reports on Start of Large-Scale Randomized Controlled Trial and Preliminary Findings from Pilot Trial on the Reduction in Complications...
COQUITLAM, BC, Canada, Jan. 19, 2021 (SEND2PRESS NEWSWIRE) -- Drink HRW is excited to announce that a large, double-blind placebo-controlled trial is set to begin this week in France, initiated by the University of Grenoble-Alpes. At the request of the researchers, Drink HRW is supplying the hydrogen tablets for the study as well as a donation to improve the size and scope of the research. It has no other involvement in the research or the decision to publish results.
TAMPA, Fla., Jan. 13, 2021 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation will host a free, live-online, and interactive symposium on Friday, Jan. 15 from 1 to 4 p.m. EST. Sponsored by Seres Therapeutics, the event is designed for patients who are being treated for a C. diff. infection in addition to those who are recovering or who have experienced recurrences. The patients, family members and caregivers will all benefit from the information and up-to-date data presented.
TAMPA, Fla., Jan. 11, 2021 (SEND2PRESS NEWSWIRE) -- While some patients diagnosed with Clostridioides difficile (C. diff., C. difficile, CDI) believe they have run into clinical trial roadblocks, due to the recent focus on the pandemic, the C Diff Foundation wants them to know they are not out of options. Safe and active clinical trials continue.
Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act...
AUSTIN, Texas, Nov. 17, 2020 (SEND2PRESS NEWSWIRE) -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.
2020 International Clostridioides difficile (C. diff., C. difficile) Virtual Conference and Health EXPO Nov. 14
TAMPA, Fla., Nov. 11, 2020 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the 8th Annual International C. diff. Virtual-Online Conference and Health EXPO will be a 5-1/2 hour online program with over fourteen international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies.
VENTURA, Calif. /California Newswire/ -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week.
ProgenaBiome Announces Alzheimer’s Patient Recalls Daughter’s Birthday After Undergoing Fecal Transplant
VENTURA, Calif. /California Newswire/ -- Dr. Sabine Hazan, founder of ProgenaBiome, a genetic sequencing lab in California, achieved rapid improvement in Alzheimer's disease (AD) symptoms in an 82-year-old male patient following fecal microbiota transplantation (FMT).
NED Biosystems Announces Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor
CAMBRIDGE, Mass., Oct. 6, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.
Leading Experts in Cancer Research Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board
CAMBRIDGE, Mass., Sept. 2, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing oral therapies for cancer and novel coronavirus, is pleased to announce that Nabeel El-Bardeesy, PhD and Razelle Kurzrock, MD have joined the Company's Scientific Advisory Board.
STONY BROOK, N.Y., July 20, 2020 (SEND2PRESSN NEWSWIRE) -- Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok's secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster.
ROKiT Pharma Pre-clinical Studies Show Tremendous Promise for Naturally Derived Cancer Drug, ROK-001
LOS ANGELES, Calif. /California Newswire/ -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
YAP, Micronesia, March 18, 2020 (SEND2PRESS NEWSWIRE) -- Schizophrenia may find a cure in individualized treatment. So says a new article in the science journal Holistic Nursing Practice. According to Dr. Daniel Helman, a researcher on the small island of Yap in Micronesia, long-term recovery is often possible, but appropriate studies are not being done.
DALLAS, Texas, March 10, 2020 (SEND2PRESS NEWSWIRE) -- Susan G. Komen Dallas County (Komen Dallas County) today said it has received bequests from the Estate of Edith Beutell and the Estate of Dr. Glenn Dodwell, which combined total more than $199,000. The gifts will further the organization's ability to assess the state of breast health in Dallas County and create plans of action to reduce breast cancer mortality disparities in the community.
SAN DIEGO, Calif. /California Newswire/ -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation's Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with early Lyme disease from multiple endemic regions across the country.
ROSELAND, N.J., Feb. 27, 2020 (SEND2PRESS NEWSWIRE) -- The Sudden Unexplained Death in Childhood (SUDC) Foundation thanks Alabama, Arkansas, Florida, Georgia, Hawaii, Illinois, Iowa, Louisiana, Massachusetts, Mississippi, New Hampshire, New York, North Carolina, North Dakota, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, West Virginia for making statewide proclamations declaring March 2020 SUDC Awareness Month.
Susan G. Komen North Jersey Announces Award Honorees Robert C. Garrett, Amparo Aguirre and LAX for the Cure
PARSIPPANY, N.J., Feb. 18, 2020 (SEND2PRESS NEWSWIRE) -- Susan G. Komen® North Jersey today announced its Pink Tie Party honorees to be recognized during the March 21st event being held at Ruth's Chris Steak House in Jersey City. For over twenty years, Susan G. Komen North Jersey has helped those who can't pay for treatments, worked to ensure that all people get the care they need, fought for the rights of patients with policy makers and funded breakthroughs in research that saves lives.
Introducing The CALNOC Nightingale Research Fund: Raising Nursing’s Voice in Health Services Research
WALNUT CREEK, Calif. /California Newswire/ -- CALNOC is pleased to introduce The CALNOC Nightingale Research Fund, an innovative and opportune resource in health services research focused on and administrated by nursing. We are excited to announce the Research Fund today in honor of Florence Nightingale and in celebration of the Year of the Nurse 2020.
CINCINNATI, Ohio, Nov. 22, 2019 (SEND2PRESS NEWSWIRE) -- The OLFACT Test Battery, developed by Osmic Enterprises, was initially developed to detect olfactory impairments. Now, it's been adapted as an automated, self-administered screening test to predict Alzheimer's disease/dementia and is being tested by a number of prominent physicians and research laboratories around the United States and in China.
SAN DIEGO, Calif. /California Newswire/ -- SciScore announces the release of its innovative solution, the first and only working application of its kind, in support of the pre-clinical scientific research community's pursuit of reproducibility and transparency.
iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting
STONY BROOK, N.Y., Nov. 14, 2019 (SEND@PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.
NEW PORT RICHEY, Fla., Nov. 14, 2019 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation reemphasizes that the month of November is "C. diff. awareness month" and is being recognized with its partners around the globe again in 2019.
AUSTIN, Texas, Nov. 1, 2019 (SEND2PRESS NEWSWIRE) -- The National Deaf Chamber of Commerce (NDCOC), the first organization truly dedicated to advocating and protecting the interests of the Deaf business community, is pleased to announce its Board of Directors, Gina D'Amore, Michael Pimentel, Evan Winegard, and Jared Allebest.
NEW YORK, N.Y., Oct. 16, 2019 (SEND2PRESS NEWSWIRE) -- The Lupus Research Alliance (LRA) is pleased to announce that seasoned professional Penny Mitchell has joined the organization as Senior Director of Marketing and Communications. In her new role, Ms. Mitchell will oversee the organization's strategic communications approach to leading lupus research worldwide and the value of participation by all sectors of the lupus community.
C Diff Foundation’s Junior Infection Fighters Program Takes Action against Harmful Germs One Community at a Time Worldwide
NEW PORT RICHEY, Fla., Oct. 16, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the inaugural C Diff Foundation Junior Infection Fighter Program was introduced to families and their children/teens in Chester County, Pennsylvania on October 12, 2019.
C Diff Foundation Raises Clostridioides difficile Awareness in St. Louis on Nov. 6-7 at 7th Annual International Conference and Health EXPO
ST. LOUIS, Mo., Oct. 14, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the 7th Annual International C. diff. Conference and Health EXPO is honored to welcome over 30 international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies. November 6 - 7, 2019 at the DoubleTree by Hilton Westport Hotel.
Neurotech Leaders Forum 2019 in San Francisco: Fifteen Neurotechnology Startups to Present at the Event
SAN FRANCISCO, Calif. /California Newswire/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.
NEW YORK, N.Y., Oct. 4, 2019 (SEND2PRESS NEWSWIRE) -- Join New York's lupus community and the Lupus Research Alliance (LRA) Saturday, October 12 to Walk with Us to Cure Lupus at the Intrepid Sea, Air & Space Museum in Manhattan.
Susan G. Komen North Jersey’s MORE THAN PINK Wellness Expo, Presented by Aetna, Comes to Jersey City, NJ Sunday, October 6
JERSEY CITY, N.J., Oct. 1, 2019 (SEND2PRESS NEWSWIRE) -- Susan G. Komen North Jersey, will be holding its MORE THAN PINK Wellness Expo on Sunday, October 6, 2019 at the Harborside Atrium in Jersey City from 12 p.m. - 4 p.m. This interactive health and wellness expo will offer attendees convenient access to education and critical health screening services, health/wellness exhibits, fitness/nutrition demonstrations, survivor support, a senior pavilion, medical information and genetic testing.
WEEHAWKEN, N.J., Oct. 1, 2019 (SEND2PRESS NEWSWIRE) -- Susan G. Komen North Jersey announced today it presented its inaugural Community Impact Award to Arthur Imperatore Sr., Founder and resident of NY Waterway, the largest commuter ferry fleet in New York Harbor, providing commuter ferry and bus services between New Jersey and Manhattan.
SYOSSET, N.Y., Sept., 20, 2019 (SEND2PRESS NEWSWIRE) -- Fluid Metering, Inc., a pioneer in design and manufacturing of high-performance fluid handling solutions, is pleased to announce a new distribution agreement with REVODIX Inc. This partnership leverages the combined strength of Fluid Metering's ultra-precise fluid control products with REVODIX's dedicated focus and distribution expertise.
C.diff. International Conference and Health EXPO Will Deliver Up-to-date Clostridioides difficile Data + More Nov. 6-7 In St. Louis
ST. LOUIS, Mo., July 11, 2019 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation is honored to welcome 30+ international leading topic experts from hospitals, pharma, biotech, academia, and Government agencies to deliver and discuss critical information on global healthcare-associated issues.
Founder of Stillbrave Childhood Cancer Foundation to Run 206-Mile Ultra-Marathon on Mount St. Helens Volcano
BURKE, Va., July 1, 2019 (SEND2PRESS NEWSWIRE) -- Stillbrave Childhood Cancer Foundation announced that its founder and director, "Tattoo Tom" Mitchell is on a mission to raise $500,000 to support children with cancer and their families. From August 9 through 13, he will return to Mount St. Helens to make his fourth attempt at what's been called "the most challenging endurance race in North America" - the Bigfoot 200.
2019 Lupus Insight Prize Awarded to Dr. Ignacio Sanz: Recognizes Studies of Harmful Immune Cells in Lupus
BOSTON, Mass., June 19, 2019 (SEND2PRESS NEWSWIRE) -- The Lupus Research Alliance has awarded its 2019 Lupus Insight Prize to Ignacio Sanz, MD, for discovering that certain little-understood immune system cells are a major source of the harmful proteins that promote lupus symptoms. His work could spark new treatments for the disease and help doctors determine which patients could benefit from current drugs.
World Renowned C Diff Foundation Announces First Ever Appointment of Paul Feuerstadt, M.D. as Director of Medical Education
NEW PORT RICHEY, Fla., May 22, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation, a one hundred percent volunteer, world renowned 501(c)(3) not-for-profit organization, has appointed nationally renowned Gastroenterologist, Dr. Paul Feuerstadt as its first Director of Medical Education.
New Research Sheds Light on Potential Role of Febrile Seizures and Other Risk Factors in Sudden Deaths in Children
ROSELAND, N.J., April 26, 2019 (SEND2PRESS NEWSWIRE) -- The SUDC Foundation highlights newly-published research from the Journal of American Medical Association (JAMA) that identifies an increased rate of febrile seizures among children who die suddenly, both with and without explanation. The authors of the article report the need for more research.
TEANECK, N.J., April 16, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that registration is now open for the 3rd Annual Global C.diff. Awareness 2K Walks. The events, which will take place at the Morris A. Votee Park, Teaneck, N.J., Charlestown Township Park, Phoenixville, Pa., and Sims Park, New Port Richey, Fla., will be hosted by the C Diff Foundation on Saturday, May 18, 2019 from 8 a.m. - 12 p.m.
12Page 1 of 2